Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
An investigator initiated and conducted, multicentre, international, double-blinded,
placebo-controlled, parallel-group, randomised controlled trial to determine the effect of
more intensive blood pressure control provided by a fixed low-dose combination blood pressure
lowering pill ("Triple Pill") strategy on top of standard of care, on time to first
occurrence of recurrent stroke in patients with a history of stroke due to intracerebral
haemorrhage.